Steady Rise in U.S. Cases of Tick-Borne Babesiosis Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 9, 2024.

WEDNESDAY, Oct. 9, 2024 -- Cases of a tick-borne parasitic disease have steadily increased in recent years, a new study shows.

Rates of babesiosis increased an average 9% a year in the United States between 2015 and 2022, researchers reported in the journal Open Forum Infectious Diseases.

Further, four in 10 patients with babesiosis also were infected with other tick-borne illnesses like Lyme disease, researchers said.

“These findings suggest that clinicians should have a heightened vigilance of co-infection of other tick-borne illness among patients admitted with babesiosis,” said lead researcher Dr. Paddy Ssentongo, an infectious disease fellow with Penn State Health Milton S. Hershey Medical Center. “Ticks can carry other bacteria that cause Lyme disease and other tick-borne diseases like anaplasmosis and ehrlichiosis.”

Babesiosis is sometimes referred to as “American malaria,” because the babesia parasite infects a person’s red blood cells similarly to malaria, researchers explained in background notes.

The parasite is transmitted by the bite of black-legged ticks, and is found primarily in Northeastern and Midwestern states.

Infected people often experience flu-like symptoms, researchers said. The disease can be deadly for older adults, people with compromised immune systems or for those who lack a spleen.

For the study, researchers analyzed national health data for more than 250 million people in the United States and identified more than 3,500 people infected with babesiosis between October 2015 and December 2022.

Cases peaked during the summer months, and most occurred in Northeastern states, results showed.

Of those diagnosed with babesiosis, 42% also had one or more additional tick-borne infections. Of those patients, 41% had Lyme disease, results show.

However, the presence of more than one infection from ticks did not increase people’s risk of death.

“Having both babesiosis and Lyme disease seemed not to be associated with worse mortality,” Ssentongo said, noting the finding was surprising. “It’s speculated that the concurrent presence of other tick-borne infections in the blood could alter the immune response by possibly ‘boosting’ it to effectively fight infections.”

It’s also possible that doxycycline -- the first-line antibiotic treatment for Lyme disease -- might also be effective against the babesia parasite, Ssentongo said.

“For patients with babesiosis, we add on doxycycline as we’re investigating whether or not the patient has Lyme disease or other tick-borne diseases, and we’ve seen better outcomes at our medical center with this approach,” Ssentongo said in a Penn State news release.

Climate change might play a role in the higher rates of babesiosis, increasing the presence and activity of ticks across a wider area, Ssentongo said. Warmer weather and heavier rainfall also could influence the activity of animals like deer that serve as reservoir hosts for the babesia parasite.

“If you live in areas where babesiosis is endemic, mostly states in the Northeast and the Midwest, take precautions, especially during the summer months,” Ssentongo said. “Practice tick-bite prevention practices. Wear long-sleeved shirts and pants and light-colored clothes. Use tick repellant and check for ticks after spending time outdoors.”

Sources

  • Penn State, news release, Oct. 8, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-10 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords